NANOMATRONIX LLC
Fayetteville, AR · Biotech
AMBIT: a microphysiological brain-chip system that applies mechanical insult to model traumatic brain injury and blood-brain barrier dysfunction for drug discovery and testing
nanomatronix.com →- Grants
- $2.8M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Energy · Phase I · Refinement and Optimization of a Novel Synthesis Method to Semi-Continuously Extrude Pure, Ultra-Long Carbon Nanotubes (CNTs) for Application as RAD Hard, Light-weight Electrical Conductors and Signal Transmission Lines | $150,000 | |
| Federal grant | National Aeronautics and Space Administration · Phase I · Thermally Partially Reduced Graphene Oxide Membranes for Water Recovery from Wastewater | $123,422 | |
| Federal grant | Department of Defense · Phase II · Development of a Ruggedized, Drop-in Replaceable QSFP+ Fiber Optic Transceiver Module for Harsh Environment Applications | $449,990 | |
| Federal grant | Department of Defense · Phase I · Development of the Bioinfusion Reactor for Skeletal Muscle Regeneration (bioSKMR) Scaffolds | $24,999 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: The AMBIT Organ-on-Chip Platform: Advanced Microphysiological Brain Injury Technology | $244,984 | |
| Federal grant | National Aeronautics and Space Administration · Phase II · Efficient Neuromorphic Processor Design for Autonomous Space Operation | $754,045 | |
| Federal grant | Department of Defense · Phase II · The AMBIT Platform: An In Vitro System for Traumatic Brain Injury R&D | $1,099,994 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3282 | TARGETSITE THERAPEUTICS CORPORATION | — | — |
| 3283 | Seranova Bio, Inc. | — | $15M |
| 3284 | NUBAD LLC | — | — |
| 3285 | NANOMATRONIX LLC | — | — |
| 3286 | PRECISION BIOTOOLS INC | — | — |
| 3287 | Athletic DNA, Inc. | — | $4.2M |
| 3288 | AMPLIFICA HOLDINGS GROUP, INC. | — | $28M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.